These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29912438)

  • 1. An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.
    Lal S; Carrera D; Phillips JJ; Weiss WA; Raffel C
    Neuro Oncol; 2018 Nov; 20(12):1606-1615. PubMed ID: 29912438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.
    Lal S; Raffel C
    Methods Mol Biol; 2022; 2423():165-177. PubMed ID: 34978698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of medulloblastoma with a modified measles virus.
    Studebaker AW; Kreofsky CR; Pierson CR; Russell SJ; Galanis E; Raffel C
    Neuro Oncol; 2010 Oct; 12(10):1034-42. PubMed ID: 20494960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.
    Hutzen B; Bid HK; Houghton PJ; Pierson CR; Powell K; Bratasz A; Raffel C; Studebaker AW
    BMC Cancer; 2014 Mar; 14():206. PubMed ID: 24646176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.
    Studebaker AW; Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C
    Neuro Oncol; 2012 Apr; 14(4):459-70. PubMed ID: 22307474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice.
    Lal S; Peng KW; Steele MB; Jenks N; Ma H; Kohanbash G; Phillips JJ; Raffel C
    Hum Gene Ther Clin Dev; 2016 Dec; 27(4):145-151. PubMed ID: 27604429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.
    Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C; Studebaker AW
    BMC Cancer; 2012 Nov; 12():508. PubMed ID: 23134812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
    Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
    Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
    Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
    PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.
    Zhang SC; Wang WL; Cai WS; Jiang KL; Yuan ZW
    BMC Cancer; 2012 Sep; 12():427. PubMed ID: 23009685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
    Friedman GK; Moore BP; Nan L; Kelly VM; Etminan T; Langford CP; Xu H; Han X; Markert JM; Beierle EA; Gillespie GY
    Neuro Oncol; 2016 Feb; 18(2):227-35. PubMed ID: 26188016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
    Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
    Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
    Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
    Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.
    Jing Y; Tong C; Zhang J; Nakamura T; Iankov I; Russell SJ; Merchan JR
    Cancer Res; 2009 Feb; 69(4):1459-68. PubMed ID: 19208845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy.
    Xia M; Luo D; Dong J; Zheng M; Meng G; Wu J; Wei J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):408. PubMed ID: 31533779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response.
    Gauvrit A; Brandler S; Sapede-Peroz C; Boisgerault N; Tangy F; Gregoire M
    Cancer Res; 2008 Jun; 68(12):4882-92. PubMed ID: 18559536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
    Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
    Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.
    Lun XQ; Zhou H; Alain T; Sun B; Wang L; Barrett JW; Stanford MM; McFadden G; Bell J; Senger DL; Forsyth PA
    Cancer Res; 2007 Sep; 67(18):8818-27. PubMed ID: 17875723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.